These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30947653)

  • 1. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
    Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
    Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
    Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
    Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugging sphingosine kinases.
    Santos WL; Lynch KR
    ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
    Plano D; Amin S; Sharma AK
    J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.
    Evangelisti C; Evangelisti C; Buontempo F; Lonetti A; Orsini E; Chiarini F; Barata JT; Pyne S; Pyne NJ; Martelli AM
    Leukemia; 2016 Nov; 30(11):2142-2151. PubMed ID: 27461062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a better sphingosine kinase-1 inhibitor.
    Lynch KR
    Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.
    Kennedy AJ; Mathews TP; Kharel Y; Field SD; Moyer ML; East JE; Houck JD; Lynch KR; Macdonald TL
    J Med Chem; 2011 May; 54(10):3524-48. PubMed ID: 21495716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure guided design of a series of sphingosine kinase (SphK) inhibitors.
    Gustin DJ; Li Y; Brown ML; Min X; Schmitt MJ; Wanska M; Wang X; Connors R; Johnstone S; Cardozo M; Cheng AC; Jeffries S; Franks B; Li S; Shen S; Wong M; Wesche H; Xu G; Carlson TJ; Plant M; Morgenstern K; Rex K; Schmitt J; Coxon A; Walker N; Kayser F; Wang Z
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4608-16. PubMed ID: 23845219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
    Lynch KR; Thorpe SB; Santos WL
    Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.
    Raje MR; Knott K; Kharel Y; Bissel P; Lynch KR; Santos WL
    Bioorg Med Chem; 2012 Jan; 20(1):183-94. PubMed ID: 22137932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and functional roles of sphingosine kinases.
    Alemany R; van Koppen CJ; Danneberg K; Ter Braak M; Meyer Zu Heringdorf D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):413-28. PubMed ID: 17242884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic properties of sphingosine kinases in haematological malignancies.
    Wallington-Beddoe CT; Bradstock KF; Bendall LJ
    Br J Haematol; 2013 Jun; 161(5):623-638. PubMed ID: 23521541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
    Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
    J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
    Chen J; Tang H; Sysol JR; Moreno-Vinasco L; Shioura KM; Chen T; Gorshkova I; Wang L; Huang LS; Usatyuk PV; Sammani S; Zhou G; Raj JU; Garcia JG; Berdyshev E; Yuan JX; Natarajan V; Machado RF
    Am J Respir Crit Care Med; 2014 Nov; 190(9):1032-43. PubMed ID: 25180446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
    Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
    Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.
    Billich A; Bornancin F; Dévay P; Mechtcheriakova D; Urtz N; Baumruker T
    J Biol Chem; 2003 Nov; 278(48):47408-15. PubMed ID: 13129923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
    Childress ES; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
    J Med Chem; 2017 May; 60(9):3933-3957. PubMed ID: 28406646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase inhibitors: A patent review.
    Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
    Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.